Healthcare provider profile · identity verified

Mutena B. Korman, M.D.

Family Practice · MERRILLVILLE, IN · NPI 1891893491

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	986	94
Pantoprazole Sodium	Pantoprazole Sodium	774	71
Lisinopril	Lisinopril	514	41
Amlodipine Besylate	Amlodipine Besylate	498	53
Levothyroxine Sodium	Levothyroxine Sodium	462	46
Donepezil Hcl	Donepezil Hcl	442	34
Sertraline Hcl	Sertraline Hcl	394	34
Gabapentin	Gabapentin	344	39
Memantine Hcl	Memantine Hcl	338	24
Clopidogrel	Clopidogrel Bisulfate	286	26
Metoprolol Tartrate	Metoprolol Tartrate	255	32
Furosemide	Furosemide	240	30
Carvedilol	Carvedilol	231	18
Escitalopram Oxalate	Escitalopram Oxalate	230	15
Eliquis	Apixaban	221	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	213	43
Metoprolol Succinate	Metoprolol Succinate	211	24
Trazodone Hcl	Trazodone Hcl	210	18
Tamsulosin Hcl	Tamsulosin Hcl	194	20
Lorazepam	Lorazepam	172	20
Potassium Chloride	Potassium Chloride	152	23
Bumetanide	Bumetanide	150	21
Farxiga	Dapagliflozin Propanediol	145	21
Omeprazole	Omeprazole	138	14
Mirtazapine	Mirtazapine	125	13
Sucralfate	Sucralfate	122	11
Carbidopa-Levodopa	Carbidopa/Levodopa	112	12
Duloxetine Hcl	Duloxetine Hcl	111	13
Levetiracetam	Levetiracetam	111	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	23
Allopurinol	Allopurinol	99	suppressed
Simvastatin	Simvastatin	98	13
Meloxicam	Meloxicam	92	suppressed
Hydralazine Hcl	Hydralazine Hcl	91	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	90	19
Hydrochlorothiazide	Hydrochlorothiazide	87	suppressed
Divalproex Sodium	Divalproex Sodium	83	suppressed
Metformin Hcl	Metformin Hcl	82	suppressed
Montelukast Sodium	Montelukast Sodium	82	11
Losartan Potassium	Losartan Potassium	81	12
Oxybutynin Chloride Er	Oxybutynin Chloride	80	12
Famotidine	Famotidine	79	12
Tramadol Hcl	Tramadol Hcl	79	16
Clonazepam	Clonazepam	75	suppressed
Midodrine Hcl	Midodrine Hcl	73	suppressed
Xarelto	Rivaroxaban	68	suppressed
Pregabalin	Pregabalin	67	15
Alcohol Prep Pads	Alcohol Antiseptic Pads	65	17
Tizanidine Hcl	Tizanidine Hcl	63	suppressed
Baclofen	Baclofen	62	suppressed
Prednisone	Prednisone	62	13
Brilinta	Ticagrelor	60	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	55	11
Buspirone Hcl	Buspirone Hcl	54	suppressed
Alprazolam	Alprazolam	53	suppressed
Entresto	Sacubitril/Valsartan	53	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	52	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	52	suppressed
Oxcarbazepine	Oxcarbazepine	51	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	50	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	49	18
Primidone	Primidone	48	suppressed
Benztropine Mesylate	Benztropine Mesylate	47	suppressed
Ondansetron Hcl	Ondansetron Hcl	47	suppressed
Lamotrigine	Lamotrigine	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Ibuprofen	Ibuprofen	42	12
Loperamide	Loperamide Hcl	42	22
Nifedipine Er	Nifedipine	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Latanoprost	Latanoprost	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Olanzapine	Olanzapine	36	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	35	13
Irbesartan	Irbesartan	35	suppressed
Azithromycin	Azithromycin	33	26
Humalog Kwikpen U-100	Insulin Lispro	33	13
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Ozempic	Semaglutide	31	suppressed
Cilostazol	Cilostazol	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	21
Levemir Flexpen	Insulin Detemir	30	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Risperidone	Risperidone	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	23
Jardiance	Empagliflozin	28	suppressed
Lithium Carbonate Er	Lithium Carbonate	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	13
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Finasteride	Finasteride	26	suppressed
Lacosamide	Lacosamide	26	suppressed
Lubiprostone	Lubiprostone	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Methylprednisolone	Methylprednisolone	24	22
Linzess	Linaclotide	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Ranolazine Er	Ranolazine	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	11
Aripiprazole	Aripiprazole	19	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	18	18
Admelog Solostar	Insulin Lispro	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Diazepam	Diazepam	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Roflumilast	Roflumilast	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Glycopyrrolate	Glycopyrrolate	16	suppressed
Nystatin	Nystatin	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Insulin Lispro	Insulin Lispro	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Lactulose	Lactulose	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Prolia	Denosumab	14	suppressed
Topiramate	Topiramate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Valsartan	Valsartan	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Dimethyl Fumarate	Dimethyl Fumarate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Valproic Acid	Valproic Acid	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error